Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Holley et al v. Gilead Sciences, Inc.
Case Number:
4:18-cv-06972
See also:
Court:
Nature of Suit:
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Judge:
Firms
- Ben Crump Law
- Drakulich Firm
- Goldman Ismail
- Hagens Berman
- HHP Law Group
- Hilliard & Shadowen
- Ingerman Smith
- Ketterer Browne
- Kirkland & Ellis
- Locks Law Firm
- Morgan & Morgan
- Orrick Herrington
- Parker Waichman
- Proskauer Rose
- Robinson Bradshaw
- Shook Hardy
- Sidley Austin
- Valle Makoff
Companies
Sectors & Industries:
-
May 02, 2024
Calif. Justices To Review Gilead's HIV Drug Negligence Fight
The California Supreme Court has granted Gilead Sciences Inc.'s request to review an appellate court's holding that the drugmaker must face claims it held back a safer HIV drug to maximize profits on an older medication.
-
September 29, 2023
Gilead Must Face HIV Drug Design-Defect Claims At Trial
A California federal judge has granted Gilead Sciences a partial win on some failure-to-warn claims in a yearslong legal battle with thousands of consumers alleging the pharmaceutical giant hid the side effects of its anti-HIV drug Truvada but found Gilead can't escape other allegations, including claims it defectively designed the drug.
-
May 15, 2023
Gilead HIV Drug Fight Begins Rare Summary Jury Trial
Gilead Sciences Inc.'s yearslong legal battle with consumers over consolidated claims that the pharmaceutical giant hid the side effects of its anti-HIV drug Truvada saw the start of the first of two rare summary jury trials in California federal court Monday.
-
April 19, 2023
HIV Drug Patients Fight Gilead's Bid To Toss Plaintiffs
Consumers accusing Gilead Sciences Inc. of hiding side effects of its anti-HIV drug Truvada urged a California federal judge to hold off on kicking hundreds of plaintiffs out of the case via terminating sanctions, arguing that, despite the company's claims, the patients have in fact complied with discovery.
-
March 22, 2023
No Dispute Gilead HIV Drug Causes Injuries, Patients Say
Consumers in a suit accusing Gilead Sciences of hiding side effects of the anti-HIV drug Truvada and related products asked a California federal judge on Tuesday to rule that the drug can cause kidney damage after the company's expert testimony was tossed.
-
March 12, 2021
Law Firm Admonished For 'False' Ads In Gilead HIV Drug Suit
A California federal judge Friday admonished a firm representing consumers accusing Gilead of hiding side effects of the anti-HIV drug Truvada and related products, saying the record shows the firm Hilliard Martinez Gonzales LLP is responsible for disseminating misleading advertising while also sanctioning it for violating a protective order.
-
August 24, 2020
Gilead Says Law Firm's Ads Misrepresent HIV Drug Suit
Gilead Sciences Inc. has asked a California federal court to admonish a plaintiffs firm representing people who have taken the anti-HIV drug Truvada and related products, alleging that the firm's ads raising the alarm about the drug's effects are irresponsible and have harmed those who could benefit from the drug.